相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time
C. Cluze et al.
ANNALS OF ONCOLOGY (2012)
Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer
Jennifer C. Livaudais et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study
Annette Wigertz et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review
M. Banning
EUROPEAN JOURNAL OF CANCER CARE (2012)
Influence of Race, Insurance, Socioeconomic Status, and Hospital Type on Receipt of Guideline-Concordant Adjuvant Systemic Therapy for Locoregional Breast Cancers
Xiao-Cheng Wu et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer
N. Lynn Henry et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial
Eleanor Mann et al.
LANCET ONCOLOGY (2012)
Age-Specific Nonpersistence of Endocrine Therapy in Postmenopausal Patients Diagnosed with Hormone Receptor-Positive Breast Cancer: A TEAM Study Analysis
Willemien van de Water et al.
ONCOLOGIST (2012)
Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer
Rebecca L. Sedjo et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy
Alastair M. Thompson et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
Dawn L. Hershman et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Adherence to oral endocrine treatments in women with breast cancer: can it be improved?
Sheila A. Doggrell
BREAST CANCER RESEARCH AND TREATMENT (2011)
Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work?
Uwe Gueth et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer
Larissa Nekhlyudov et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
The Impact of Breast Care Nurses on Patients' Satisfaction, Understanding of the Disease, and Adherence to Adjuvant Endocrine Therapy
Ute-Susann Albert et al.
BREAST CARE (2011)
Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer
L. Huiart et al.
BRITISH JOURNAL OF CANCER (2011)
Predicting Adherence to Tamoxifen for Breast Cancer Adjuvant Therapy and Prevention
Jennifer H. Lin et al.
CANCER PREVENTION RESEARCH (2011)
Association Between Prescription Co-Payment Amount and Compliance With Adjuvant Hormonal Therapy in Women With Early-Stage Breast Cancer
Alfred I. Neugut et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Differences Between Primary Care Physicians' and Oncologists' Knowledge, Attitudes and Practices Regarding the Care of Cancer Survivors
Arnold L. Potosky et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2011)
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
C. Davies et al.
LANCET (2011)
Adherence to long-term adjuvant hormonal therapy for breast cancer
Carolyn Gotay et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2011)
Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis
Myrthe P. P. van Herk-Sukel et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy
Peyman Hadji
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
Managing the toxicities of the aromatase inhibitors
Joanne E. Mortimer
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2010)
Effect of Concomitant CYP2D6 Inhibitor Use and Tamoxifen Adherence on Breast Cancer Recurrence in Early-Stage Breast Cancer
Vincent O. Dezentje et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Women's perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients' point of view
Isabelle Pellegrini et al.
PSYCHO-ONCOLOGY (2010)
American Society of Clinical Oncology Clinical Practice Guideline Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer
Harold J. Burstein et al.
JOURNAL OF ONCOLOGY PRACTICE (2010)
Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer
V. Ziller et al.
ANNALS OF ONCOLOGY (2009)
Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer
Lee S. Schwartzberg et al.
BREAST (2009)
Patient Adherence and Persistence With Oral Anticancer Treatment
Kathryn Ruddy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
Adjuvant Hormonal Therapy Use Among Insured, Low-Income Women With Breast Cancer
Gretchen Kimmick et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients
J. M. Rae et al.
PHARMACOGENOMICS JOURNAL (2009)
Evaluation of a group cognitive behavioural intervention for women suffering from menopausal symptoms following breast cancer treatment
Myra S. Hunter et al.
PSYCHO-ONCOLOGY (2009)
Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients
Aye Moe Thu et al.
AMERICAN JOURNAL OF SURGERY (2008)
Effectively nursing patients receiving aromatase inhibitor therapy
Y. Wengstrom
BREAST (2008)
Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer
U. Gueth et al.
BRITISH JOURNAL OF CANCER (2008)
Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer
C. McCowan et al.
BRITISH JOURNAL OF CANCER (2008)
Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer
Cynthia Owusu et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer
Ann H. Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
Norman Williams
LANCET ONCOLOGY (2008)
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors
N. Lynn Henry et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy
David Cella et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Adherence to oral endocrine therapy for breast cancer: A nursing perspective
Christine Miaskowski et al.
CLINICAL JOURNAL OF ONCOLOGY NURSING (2008)
Aromatase inhibitor-associated arthralgia and/or bone pain: Frequency and characterization in non-clinical trial patients
Cary A. Presant et al.
CLINICAL BREAST CANCER (2007)
Transition from treatment to survivorship: Effects of a psychoeducational intervention on quality of life in breast cancer survivors
Karen Dow Meneses et al.
ONCOLOGY NURSING FORUM (2007)
Patient centered experiences in breast cancer - Predicting long-term adherence to tamoxifen use
Katherine L. Kahn et al.
MEDICAL CARE (2007)
A checklist for medication compliance and persistence studies using retrospective databases
Andrew M. Peterson et al.
VALUE IN HEALTH (2007)
Side effects of aromatase inhibitors versus tamoxifen: the patients' perspective
Jennifer R. Garreau et al.
AMERICAN JOURNAL OF SURGERY (2006)
Adherence to tamoxifen over the five-year course
Timothy L. Lash et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Complementary and alternative therapies for the management of menopause-related symptoms - A systematic evidence review
Anne Nedrow et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Nonhormonal therapies for menopausal hot flashes - Systematic review and meta-analysis
HD Nelson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Adherence to endocrine therapy for breast cancer
Rowan T. Chlebowski et al.
ONCOLOGY (2006)
Benefits from an uncertainty management intervention for African-American and Caucasian older long-term breast cancer survivors
MH Mishel et al.
PSYCHO-ONCOLOGY (2005)
Adherence beliefs among breast cancer patients taking tamoxifen
EA Grunfeld et al.
PATIENT EDUCATION AND COUNSELING (2005)
Taking charge: A self-management program for women following breast cancer treatment
B Cimprich et al.
PSYCHO-ONCOLOGY (2005)
Management of menopausal symptoms in patients with breast cancer: an evidence-based approach
M Hickey et al.
LANCET ONCOLOGY (2005)
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
A Howell et al.
LANCET (2005)
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
RC Coombes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Quality of life at the end of primary treatment of breast cancer: First results from the moving beyond cancer randomized trial
PA Ganz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer
AK Fink et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer
PE Goss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
AH Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Adjuvant tamoxifen: Predictors of use, side effects, and discontinuation in older women
S Demissie et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Tolerability of hormone therapies for breast cancer: How informative are documented symptom profiles in medical notes for 'well-tolerated' treatments?
D Fellowes et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Managing menopausal symptoms in breast cancer survivors: Results of a randomized controlled trial
PA Ganz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
